| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K34485477 |
| PharmacoGx | BRD-K34485477 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TXN2 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.08 |
| mRNA | LCN10 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.08 |
| mRNA | TAS2R40 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.08 |
| mRNA | SPRYD4 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.08 |
| mRNA | C15orf59 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.08 |
| mRNA | KIAA1644 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.08 |
| mRNA | COX10 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.08 |
| mRNA | OR6C74 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.08 |
| mRNA | CEND1 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.08 |
| mRNA | NUDCD3 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.08 |
